Abstract
The importance of chemotherapy in the treatment of gastric cancer has increased after the appearance of more effective new agents such as TS-1. Therefore, the development of second line chemotherapy following TS-1 administration is needed urgently. Recently, we treated three cases of advanced and recurrent gastric cancers, using paclitaxel after TS-1 treatment. We herein describe these cases and discuss the therapeutic effect of paclitaxel and drug-related side effects in these patients.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antineoplastic Agents, Phytogenic / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Drug Administration Schedule
-
Drug Combinations
-
Female
-
Humans
-
Male
-
Middle Aged
-
Oxonic Acid / administration & dosage
-
Paclitaxel / administration & dosage*
-
Pyridines / administration & dosage
-
Stomach Neoplasms / drug therapy*
-
Tegafur / administration & dosage
Substances
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents, Phytogenic
-
Drug Combinations
-
Pyridines
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Paclitaxel